title: The role of interleukin 6 in megakaryocyte formation, megakaryocyte development and platelet production.
abstract: Megakaryocytopoiesis is the cellular amplification and differentiation of precursors into immature megakaryocytes, and the cytoplasmic maturation of these megakaryocytes, a process terminating in the release of platelets into the circulation. Interleukin 6 (IL-6) stimulates megakaryocytopoiesis in the bone marrow, increasing platelet numbers in the circulation. IL-6 alone is poorly active on the growth of stem cell populations, but acts in synergy with stem cell factor (c-kit ligand) to expand the committed myeloid progenitor compartments but not the megakaryocyte progenitors. IL-6 has a direct action on megakaryocyte progenitors but only in synergy with low doses of interleukin 3 (IL-3), increasing the number of immature megakaryocytes and enhancing the processes of development into mature megakaryocytes. IL-6 is about 10 times more active on megakaryocytes than on megakaryocyte progenitors in cell culture. It is active alone and will stimulate increases in cell size and DNA content. IL-6 does not appear to stimulate the process of platelet release. IL-6 is found in bone marrow, in both macrophage subsets and megakaryocytes, indicating that it may be an important physiological regulator of both paracrinal (microenvironmental) and autocrinal mechanisms controlling megakaryocyte development in bone marrow.
authors.affiliation: Department of Physiology, University of Melbourne, Parkville, Victoria, Australia.
authors.forename: N
authors.initials: N
authors.lastname: Williams
authors.forename: I
authors.initials: I
authors.lastname: Bertoncello
authors.forename: H
authors.initials: H
authors.lastname: Jackson
authors.forename: J
authors.initials: J
authors.lastname: Arnold
authors.forename: H
authors.initials: H
authors.lastname: Kavnoudias
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000166:cytology*; D001853:Bone Marrow / Q000187:drug effects / Q000502:physiology; D016922:Cellular Senescence / Q000187:drug effects / Q000502:physiology; D016207:Cytokines / Q000502:physiology; D005246:Feedback; D015850:Interleukin-6 / Q000494:pharmacology / Q000502:physiology*; D008533:Megakaryocytes / Q000166:cytology*; D011994:Recombinant Proteins / Q000494:pharmacology
chemical_list: D016207:Cytokines; D015850:Interleukin-6; D011994:Recombinant Proteins